BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1061 related articles for article (PubMed ID: 17001233)

  • 1. Clinical outcome of patients undergoing low aggressive angioplasty combined with brachytherapy and short-term dual antiplatelet therapy for in-stent restenosis.
    Di Pede F; Buja P; Millosevich P; Grassi G; Celestre M; Zuin G; Marchetti C; Pizzi G; Antonello M; Bindoni L; Raviele A
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):731-6. PubMed ID: 17001233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-stent restenosis.
    Holmes DR
    Rev Cardiovasc Med; 2001; 2(3):115-9. PubMed ID: 12439375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary radiotherapy with a (188)rhenium liquid-filled PTCA balloon system in in-stent restenosis: acute and long-term angiographic results, as well as 1-year clinical follow-up.
    Reynen K; Köckeritz U; Kropp J; Wunderlich G; Knapp FF; Schmeisser A; Strasser RH
    Int J Cardiol; 2004 May; 95(1):29-34. PubMed ID: 15159034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular responses to the multiple overlapped paclitaxel-eluting stents for the treatment of bare-metal in-stent restenotic lesions: angiographic and intravascular ultrasound analysis from the TAXUS-V ISR trial.
    Koizumi T; Fitzgerald PJ; Honda Y; Ellis SG; Kent K; Martin SL; Brown CL; Masud AR; Patterson JB; Greenberg J; Friedman M; Uchida T; Stone GW
    Cardiovasc Revasc Med; 2010; 11(3):140-8. PubMed ID: 20599163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary 166Holmium brachytherapy combined with cutting balloon angioplasty for the treatment of in-stent restenosis.
    Park S; Kang WC; Rhee JH; Ko YG; Choi D; Jang Y; Lee JD; Shim WH; Cho SY
    Cardiovasc Radiat Med; 2003; 4(3):119-25. PubMed ID: 14984711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeat intracoronary beta-brachytherapy using a rhenium-188-filled balloon catheter for recurrent restenosis in patients who failed intracoronary radiation therapy.
    Wöhrle J; Krause BJ; Nusser T; Kochs M; Höher M
    Cardiovasc Revasc Med; 2006; 7(1):2-6. PubMed ID: 16513516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged double antiplatelet therapy in a cohort of "de novo" diabetic patients treated with drug-eluting stent implantation.
    Mollichelli N; Morici N; Ambrogi F; Latib A; Boracchi P; Godino C; Ferri L; Ielasi A; Chieffo A; Montorfano M; Colombo A
    Am J Cardiol; 2010 May; 105(10):1395-401. PubMed ID: 20451684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous therapy of bifurcation lesions with drug-eluting stent implantation: the Culotte technique revisited.
    Hoye A; van Mieghem CA; Ong AT; Aoki J; Rodriguez Granillo GA; Valgimigli M; Tsuchida K; Sianos G; McFadden EP; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Int J Cardiovasc Intervent; 2005; 7(1):36-40. PubMed ID: 16019613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medium-term results from the clinical and angiographic follow-up of patients after angioplasty and implantation of sirolimus-eluting stents.
    Dardas PS; Tsikaderis DD; Mezilis NE; Hatzimiltiadis S
    Hellenic J Cardiol; 2005; 46(2):117-23. PubMed ID: 15847131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provisional stenting for multivessel PCI.
    Han B; Liu L; Aboud M; Nahir M; Hasin Y
    Int J Cardiovasc Intervent; 2005; 7(1):46-51. PubMed ID: 16019615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracoronary beta brachytherapy as a treatment option for high-risk refractory in-stent restenosis; Compassionate use.
    Kim S; Almeda FQ; Tessalee M; Snell RJ; Nathan S; Thew S; Nguyen C; Chu JC; Schaer GL
    Cardiovasc Radiat Med; 2004; 5(1):9-14. PubMed ID: 15275626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of sirolimus-eluting stent implantation for treatment of in-stent restenosis after brachytherapy failure.
    Iakovou I; Sangiorgi GM; Stankovic G; Corvaja N; Michev I; Chieffo A; Rogacka R; Vitrella G; Airoldi F; Colombo A
    Am J Cardiol; 2004 Aug; 94(3):351-4. PubMed ID: 15276103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of barotrauma on acute and late angiographic and clinical outcomes following angioplasty and beta-irradiation of coronary in-stent restenotic lesions.
    Schiele TM; König A; Rieber J; Krötz F; Sohn HY; Kantlehner R; Pöllinger B; Dühmke E; Theisen K; Siebert U; Klauss V
    J Invasive Cardiol; 2004 Jan; 16(1):14-9. PubMed ID: 14699217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
    Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
    JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of restenosis and disease progression on clinical outcome after multivessel stenting in diabetic patients.
    Loutfi M; Mulvihill NT; Boccalatte M; Farah B; Fajadet J; Marco J
    Catheter Cardiovasc Interv; 2003 Apr; 58(4):451-4. PubMed ID: 12652493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes.
    Lemos PA; van Mieghem CA; Arampatzis CA; Hoye A; Ong AT; McFadden E; Sianos G; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Circulation; 2004 Jun; 109(21):2500-2. PubMed ID: 15148279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor outcome in patients treated with brachytherapy for diffuse in-stent restenosis. The role of additional stenting despite prolonged antiplatelet therapy.
    Zavalloni D; Rossi M; Belli G; Scatturin M; Morenghi E; Marsico F; Catalano G; Tosi G; Pagnotta P; Presbitero P
    J Invasive Cardiol; 2005 Nov; 17(11):598-602. PubMed ID: 16264205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions.
    Mauri L; Kereiakes DJ; Normand SL; Wiviott SD; Cohen DJ; Holmes DR; Bangalore S; Cutlip DE; Pencina M; Massaro JM
    Am Heart J; 2010 Dec; 160(6):1035-41, 1041.e1. PubMed ID: 21146655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Single-center experience with the Palmaz-Schatz intracoronary stent: the immediate results and medium- and long-term follow-up].
    Galassi AR; Tamburino C; Grassi R; Monaco A; Russo G; Ierna SM; Calvi V; Giuffrida G
    Cardiologia; 1996 Nov; 41(11):1097-105. PubMed ID: 9064207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes after treatment of diffuse in-stent restenosis with rotational atherectomy followed by beta-radiation therapy with a 188Re-MAG3-filled balloon.
    Lee SW; Park SW; Hong MK; Kim YH; Lee JH; Park JH; Moon DH; Oh SJ; Lee CW; Kim JJ; Park SJ
    Int J Cardiol; 2005 Mar; 99(2):201-5. PubMed ID: 15749176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.